按关键词阅读：
对菌群进行精确调控 ， 需要对微生态调节剂进行大规模的体外研究 ， 以了解调节剂与不同生态系统群落间的相互作用 ， 以及健康个体与患者之间应变水平的差异 。
因此 ， 综合运用合成生态学方法、分离法、筛选法、高通量组学监测和建模法（图 1） ， 对开发有效微生物疗法至关重要 。
参考文献：
1. Vázquez-Castellanos, J. F., Biclot, A., Vrancken, G., Huys, G. R. & Raes, J. Design of synthetic microbial consortia for gut microbiota modulation. Curr. Opin. Pharmacol. 49, 52–59 (2019).
2. El Hage, R., Hernandez-Sanabria, E. & Van de Wiele, T. Emerging trends in “smart probiotics”: functional consideration for the development of novel health and industrial applications. Front. Microbiol. 8, 1889 (2017).
3. Clemente, J. C., Manasson, J. & Scher, J. U. The role of the gut microbiome in systemic inflammatory disease. BMJ 360, j5145 (2018).
4. Mills, S., Ross, R. P. & Hill, C. Bacteriocins and bacteriophage; a narrow-minded approach to food and gut microbiology. FEMS Microbiol. Rev. 41, S129–S153 (2017).
5. Vieira-Silva, S. et al. Statin therapy is associated with lower prevalence of gut microbiota dysbiosis. Nature 581, 310–315 (2020).
6. Vrancken, G., Gregory, A. C., Huys, G. R., Faust, K. & Raes, J. Synthetic ecology of the human gut microbiota. Nat. Rev. Microbiol. 17, 754–76 (2019).
7. Tramontano, M. et al. Nutritional preferences of human gut bacteria reveal their metabolic idiosyncrasies. Nat. Microbiol. 3, 514–522 (2018).
8. Maier, L. et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555, 623–628 (2018).
9. Hernandez-Sanabria, E. et al. Short-term supplementation of celecoxib-shifted butyrate production on a simulated model of the gut microbial ecosystem and ameliorated in vitro inflammation. NPJ Biofilms Microbiomes 6, 1–12 (2020).
10. Muller, E. E. et al. Using metabolic networks to resolve ecological properties of microbiomes. Curr. Opin. Syst. Biol. 8, 73–80 (2018).
作者｜Emma Hernandez-Sanabria、Jorge Francisco Vázquez-Castellanos and Jeroen Raes
编译｜ninety
【知识科普|Nature子刊：微生物组疗法想要成功，少不了这个方法】审校｜617
稿源：(热心肠先生)
【】网址：http://www.shadafang.com/c/hn110Oa4X2020.html
标题：知识科普|Nature子刊：微生物组疗法想要成功，少不了这个方法( 三 )
